Mingyuan He

机构：Harbin Medical University, Yanshan University, First Affiliated Hospital of Harbin Medical University, Southern Medical University · ORCID：0000-0002-1146-616X

发表论文 60 篇 · 总被引 820 次 · h-index 17

代表论文

• CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome (2022 · Frontiers in Pharmacology · 被引 19)
• CircMap4k2 reactivated by aneurysm plication alleviates residual cardiac remodeling after SVR by enhancing cardiomyocyte proliferation in post-MI mice (2023 · Journal of Advanced Research · 被引 13)
• LCZ696 (sacubitril/valsartan) inhibits pulmonary hypertension induced right ventricular remodeling by targeting pyruvate dehydrogenase kinase 4 (2023 · Biomedicine & Pharmacotherapy · 被引 13)
• Dapagliflozin attenuates residual cardiac remodeling after surgical ventricular reconstruction in mice with an enlarged heart after myocardial infarction (2022 · Biomedicine & Pharmacotherapy · 被引 13)
• Canagliflozin reverses doxorubicin-induced cardiotoxicity via restoration of autophagic homeostasis (2024 · Toxicology and Applied Pharmacology · 被引 9)
• TBSTSleepNet: Three-branch spectro-temporal bidirectional LSTM based attention model for EEG sleep staging (2024 · Biomedical Signal Processing and Control · 被引 7)